对M1和M2的计算和实验研究与万科迈辛结合,以控制万科迈辛中间体肠球菌 faecaliscoccus
Ali Bahadori1,2, Khalil Maleki Chollou3, Leila Rahbarnia4
1Department of Medical Microbiology, Sarab Faculty of Medical Sciences, Sarab, Iran.
Probiotics and antimicrobial proteins
|July 28, 2025
概括
梅利丁 (MLT,M1,M2) 与万科米辛具有协同效应,可以对抗万科米辛中间体E. faecalis. 这种联合治疗减少了抗生素的毒性,为治疗耐药细菌感染提供了一个有希望的策略.
科学领域:
- 抗微生物是一种抗微生物.
- 细菌膜的相互作用
- 药物协同作用 药物协同作用
背景情况:
- 梅利丁 (MLT) 具有广泛的抗菌活性.
- 范科米辛中间体E. faecalis (VIE) 提出了一个重大的临床挑战.
- 需要新的治疗策略来对抗抗生素耐药性.
研究的目的:
- 评估MLT及其衍生 (M1,M2) 与万科米辛对VIE的协同抗菌作用.
- 研究与细菌膜相互作用的机制.
- 评估组合治疗的毒性概况.
主要方法:
- 在体粗粒度模拟的体膜相互作用.
- 在体外检查板测试以确定分数抑制度指数 (FICI).
- 用于毒性评估的MTT测定和血液溶解试验.
主要成果:
- 粗粒度模拟显示了M1和M2的显著膜破坏.
- 组合疗法实现了80倍的减少万科米辛的MIC.
- 通过FICI值证实了协同效应,在有效度下降了毒性.
结论:
- MLT,M1和M2具有与万科米辛对抗VIE的协同活性.
- 这种组合疗法显示出提高疗效和降低毒性的潜力.
- 这些发现表明,对于治疗耐万科素的E. faecalis感染来说,这是一个有前途的治疗方法.
相关概念视频
01:28Antimicrobial Effectiveness
163
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
163
01:27Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K